Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Elevation Oncology IncCommon stock stock
Learn how to easily invest in Elevation Oncology IncCommon stock stock.
Elevation Oncology Inc. Common stock is a biotechnology business based in the US. Elevation Oncology IncCommon stock shares (ELEV) are listed on the NASDAQ and all prices are listed in US Dollars. Elevation Oncology IncCommon stock employs 17 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Elevation Oncology IncCommon stock
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ELEV – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Elevation Oncology IncCommon stock stock price (NASDAQ: ELEV)Use our graph to track the performance of ELEV stocks over time.
Elevation Oncology IncCommon stock shares at a glance
|Latest market close||$6.00|
|52-week range||$4.15 - $16.22|
|50-day moving average||$6.23|
|200-day moving average||$8.76|
|Wall St. target price||$20.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.82|
Buy Elevation Oncology IncCommon stock shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Elevation Oncology IncCommon stock stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Elevation Oncology IncCommon stock price performance over time
|1 week (2022-01-14)||6|
|1 month (2021-12-21)||33.04%|
|3 months (2021-10-21)||-25.09%|
|6 months (2021-07-21)||-43.82%|
|1 year (2021-01-17)||N/A|
|2 years (2020-01-17)||N/A|
|3 years (2019-01-17)||N/A|
|5 years (2017-01-17)||N/A|
Elevation Oncology IncCommon stock financials
|Gross profit TTM||$0|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||$139.4 million|
TTM: trailing 12 months
Elevation Oncology IncCommon stock share dividends
We're not expecting Elevation Oncology IncCommon stock to pay a dividend over the next 12 months.
Elevation Oncology IncCommon stock overview
Elevation Oncology, Inc. , a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically-defined patient populations in the United States. Its lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. The company was incorporated in 2019 and is based in New York, New York. .
Elevation Oncology IncCommon stock in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questionsWhat percentage of Elevation Oncology IncCommon stock is owned by insiders or institutions?
Currently 21.391% of Elevation Oncology IncCommon stock shares are held by insiders and 89.317% by institutions. How many people work for Elevation Oncology IncCommon stock?
Latest data suggests 17 work at Elevation Oncology IncCommon stock. When does the fiscal year end for Elevation Oncology IncCommon stock?
Elevation Oncology IncCommon stock's fiscal year ends in December. Where is Elevation Oncology IncCommon stock based?
Elevation Oncology IncCommon stock's address is: 888 Seventh Avenue, New York, NY, United States, 10106 What is Elevation Oncology IncCommon stock's ISIN number?
Elevation Oncology IncCommon stock's international securities identification number is: US28623U1016
More guides on Finder
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Ask an Expert